Topic

Dojolvi (triheptanoin)

A collection of 39 issues

How to Get Dojolvi (Triheptanoin) Covered by Cigna in New York: Complete PA Guide with Appeal Scripts

Answer Box: Getting Dojolvi Covered by Cigna in New York Eligibility: Patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD) can get Dojolvi (triheptanoin) covered by Cigna through prior authorization. Fastest path: Submit PA with genetic testing results, metabolic specialist prescription, and documentation that no other MCT products are

How to Get Dojolvi (Triheptanoin) Covered by Blue Cross Blue Shield in Illinois: Complete PA and Appeal Guide

Answer Box: Getting Dojolvi Covered by BCBS Illinois Blue Cross Blue Shield Illinois requires prior authorization for Dojolvi (triheptanoin) with molecular confirmation of LC-FAOD. The fastest path: (1) Gather genetic test results showing pathogenic variants in CPT2, ACADVL, HADHA, or HADHB genes, (2) Have a metabolic specialist complete the PA

How to Get Dojolvi (Triheptanoin) Covered by Humana in Georgia: Complete Coding and Appeal Guide

Answer Box: Getting Dojolvi (Triheptanoin) Covered by Humana in Georgia Dojolvi (triheptanoin) requires prior authorization from Humana Medicare Advantage, billed under NDC 69794-0050-50 with ICD-10 codes E71.310 or E71.318. Your prescriber must submit molecular genetic confirmation of long-chain fatty acid oxidation disorder (LC-FAOD) plus clinical documentation. If denied,

How to Get Dojolvi (Triheptanoin) Covered by UnitedHealthcare in Pennsylvania: Complete PA Guide & Appeal Scripts

Answer Box: Getting Dojolvi Covered by UnitedHealthcare in Pennsylvania Quick Path to Approval: UnitedHealthcare requires prior authorization for Dojolvi (triheptanoin) with molecular confirmation of long-chain fatty acid oxidation disorder (LCFAOD), prescription by a board-certified medical geneticist, and no concurrent MCT oil use. If denied, Pennsylvania's new external review

How to Get Dojolvi (Triheptanoin) Covered by UnitedHealthcare in Michigan: Complete PA Guide with Appeal Scripts

Answer Box: Getting Dojolvi Covered by UnitedHealthcare in Michigan Dojolvi (triheptanoin) requires prior authorization from UnitedHealthcare for long-chain fatty acid oxidation disorders (LC-FAOD). Key requirements: molecular genetic confirmation of LC-FAOD, prescription from a board-certified medical geneticist, no concurrent MCT products, and dosing ≤35% of daily calories. First step: Download the

How to Get Dojolvi (Triheptanoin) Covered by Aetna CVS Health in Texas: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Dojolvi Covered by Aetna CVS Health in Texas Dojolvi (triheptanoin) requires prior authorization from Aetna CVS Health and is not on the 2024 formulary, requiring a formulary exception. Essential requirements include genetic/biochemical LC-FAOD confirmation, specialist documentation, and proof that dietary management alone is inadequate. First step

How to Get Dojolvi (Triheptanoin) Covered by UnitedHealthcare in Ohio: Complete Resource Guide

Quick Answer: Getting Dojolvi Covered by UnitedHealthcare in Ohio To get Dojolvi (triheptanoin) approved by UnitedHealthcare in Ohio: Submit a prior authorization through the UHC Provider Portal or fax 866-940-7328 with genetic testing confirming LC-FAOD, prescription from a board-certified medical geneticist, and documentation that no MCT products are being used

How to Get Dojolvi (triheptanoin) Covered by Cigna in Virginia: Complete Appeals Guide

Answer Box: Getting Dojolvi (triheptanoin) Covered by Cigna in Virginia Cigna requires prior authorization for Dojolvi with molecular confirmation of long-chain fatty acid oxidation disorder (LC-FAOD). Submit through CoverMyMeds or ExpressPAth with genetic test results, diagnosis codes, and clinical rationale. If denied, Virginia law provides step therapy override protections and

Getting Dojolvi (Triheptanoin) Covered by Aetna CVS Health in New York: Complete Guide to Approval, Appeals & Forms

Answer Box: Quick Path to Coverage Dojolvi (triheptanoin) is not on Aetna's 2024 formulary, requiring a formulary exception or prior authorization based on medical necessity. In New York, you have strong appeal rights through the state's external review system if initially denied. Fastest approval path: 1.